ReShape Lifesciences Inc. (RSLS) Anounces $6M Registered Direct Offering

April 2, 2018 8:34 AM EDT Send to a Friend
ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login